Preclinical Evaluation of PTK7-Targeted Radionuclide Therapy.

Mol Cancer Ther · 2025 · PMC12402794 · PMID 40495114

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

The K D values for different TCMC-conjugated antibodies showed a decreasing trend in affinity with increasing chelator-to-antibody ratios ( Table 2 ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.